Back To Schedule
Wednesday, June 27 • 4:00pm - 5:15pm
#382: Artificial Intelligence: A Disruptive Journey for Pharmacovigilance

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-673-L04-P; CME 1.25; IACET 1.25; RN 1.25

Pharmacovigilance is undergoing an unprecedented amount of change. As the global regulatory environment becomes more complex, PV departments are simultaneously faced with ever increasing volumes and varieties of safety data further stretching already limited resources. How can PV units become proactive and patient centric if they are overburdened by highly labor intensive processes? The rapidly evolving world of artificial intelligence and machine learning holds significant promise. This session will explore the real life journey of several organizations engaged in adopting cognitive computing across their PV landscape. Key considerations including how to initiate an automation odyssey, identifying targets for cognitive computing, the role of subject matter experts, and the impact of positive disruption will be explored.

Learning Objectives

Define cognitive computing and how it differs from robotic process automation; Describe the in-depth process for training cognitive systems along with the required iterative training processes; Identify key stakeholders and business impacts.


Annette S. Williams


Training Artificial Intelligent System for Pharmacovigilance: Practical Considerations and Guidance
Cartic Ramakrishnan, PhD

The Future of Pharmacovigilance After Full Industry Disruption from Cognitive Automation
Glenn Carroll, MBA

Our Journey Toward Touchless Case Management
Caroline Rosewell, MBA

avatar for Glenn Carroll

Glenn Carroll

Principal, Life Sciences Strategy, Deloitte
Glenn is a Principal in Deloitte’s Life Science practice with over 15 years of Pharmaceutical and Biotechnology consulting experience delivery strategic and operating model engagements. He has significant consulting experience in Compliance, R&D, Medical Affairs and Pharmacovigilance... Read More →
avatar for Cartic Ramakrishnan

Cartic Ramakrishnan

Senior Technical Staff Member, Lead Cognitive Scientist, Life Sciences, IBM Watson Health
Cartic Ramakrishnan is a research scientist with a background in NLP and Machine Learning. He serves as lead scientist at IBM Watson health developing solutions to problems in the biomedical and healthcare domain. Cartic's recent work has focused on the development of NLP systems... Read More →
avatar for Caroline Rosewell

Caroline Rosewell

Senior Director, Global Patient Safety, Clinical Case Management, Eli Lilly and Company
Caroline Rosewell has a BS - Monash University Australia & MBA - Indiana University U.S. Caroline started in the pharmaceutical industry in 1995 with CSL Ltd Australia & then joined Eli Lilly Australia in 2000. She has since held various pharmacovigilance (PV) roles across Australia... Read More →
avatar for Annette Williams

Annette Williams

Vice President, Lifecycle Safety, IQVIA
Annette Williams, R.Ph, is Vice President of PV Services at IQVIA, encompassing global Safety Operations (case processing and regulatory reporting), Project Management, and Safety Systems. Williams leads the exploration and adoption of innovative technologies to streamline how Lifecycle... Read More →

Wednesday June 27, 2018 4:00pm - 5:15pm
Room 253AB Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA